Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major
iKNiTO Journal Management System

Journal Management System

Rashad, N., El-Helaly, A., Radwan, A., Ibrahim, N. (2021). Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major. EKB Journal Management System, 82(2), 369-378. doi: 10.21608/ejhm.2021.144903
Nearmeen M. Rashad; Amira M. El-Helaly; Ahmed M. Radwan; Neveen F. Ibrahim. "Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major". EKB Journal Management System, 82, 2, 2021, 369-378. doi: 10.21608/ejhm.2021.144903
Rashad, N., El-Helaly, A., Radwan, A., Ibrahim, N. (2021). 'Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major', EKB Journal Management System, 82(2), pp. 369-378. doi: 10.21608/ejhm.2021.144903
Rashad, N., El-Helaly, A., Radwan, A., Ibrahim, N. Association of Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin with Secondary Hypogonadism in Egyptian Females with Beta-Thalassemia Major. EKB Journal Management System, 2021; 82(2): 369-378. doi: 10.21608/ejhm.2021.144903